BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Ipca Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524494
ISIN Demat
INE571A01038
Book Value (Rs)
314.5139046
NSE Symbol
IPCALAB
Divident Yield %
0.3
Market Cap
(Rs In Cr.)
50,945
P/E (TTM)
40.24
EPS (TTM)
49.9
Face Value
(Rs)
1
Back
Ipca Laboratories consolidated net profit rises 72.33% in the June 2026 quarter
13-Aug-26   Hrs IST

Net profit of Ipca Laboratories rose 72.33% to Rs 401.89 crore in the quarter ended June 2026 as against Rs 233.21 crore during the previous quarter ended June 2025. Sales rose 20.76% to Rs 2788.10 crore in the quarter ended June 2026 as against Rs 2308.85 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales2788.102308.85 21
OPM %24.0118.04 -
PBDT682.89430.57 59
PBT572.08330.51 73
NP401.89233.21 72

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)